Evoqua Water Technologies Acquires Renal Business from STERIS (Mar Cor / Cantel Operations)

January 3, 2022

Evoqua Water Technologies has closed the acquisition of the renal business historically operated by Mar Cor Purification and Cantel Medical, subsidiaries of STERIS Plc. The acquired business, expected to generate approximately $180 million of annualized revenue and $27 million of adjusted EBITDA (pre-synergies), expands Evoqua’s service footprint in North America and furthers its reach into the healthcare vertical.

Buyers
Evoqua Water Technologies
Targets
Mar Cor Purification (renal business), Cantel Medical (renal business), Renal business of STERIS Plc (operated by Mar Cor Purification and Cantel Medical)
Sellers
STERIS Plc
Location
Minnesota, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.